Comment
doi: 10.1016/S0140-6736(15)61206-5.
Epub 2015 Jul 23.
Postmenopausal breast cancer: a best endocrine strategy?
Affiliations
- PMID: 26211823
- DOI: 10.1016/S0140-6736(15)61206-5
Item in Clipboard
Comment
Postmenopausal breast cancer: a best endocrine strategy?
Lancet.
.
Free article
No abstract available
Comment on
-
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.Lancet. 2015 Oct 3;386(10001):1341-1352. doi: 10.1016/S0140-6736(15)61074-1. Epub 2015 Jul 23. Lancet. 2015. PMID: 26211827
Similar articles
-
[Advancement in endocrine therapy for breast cancer].Ai Zheng. 2007 Apr;26(4):440-4. Ai Zheng. 2007. PMID: 17430670 Review. Chinese.
-
Aromatase inhibitors for breast cancer.Rev Endocr Metab Disord. 2007 Sep;8(3):215-28. doi: 10.1007/s11154-007-9039-z. Rev Endocr Metab Disord. 2007. PMID: 17486453 Review.
-
Effect of a switch of aromatase inhibitors to another aromatase inhibitor or tamoxifen on musculoskeletal symptoms in breast cancer; Which is the best?J BUON. 2020 Jul-Aug;25(4):2132. J BUON. 2020. PMID: 33099971 No abstract available.
-
Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology.Clin Cancer Res. 2006 Sep 15;12(18):5603. doi: 10.1158/1078-0432.CCR-06-0897. Clin Cancer Res. 2006. PMID: 17000698 No abstract available.
-
Commentary: optimal adjuvant endocrine therapy of postmenopausal breast cancer.Int J Fertil Womens Med. 2005 Sep-Oct;50(5 Pt 1):197-8. Int J Fertil Womens Med. 2005. PMID: 16468468
Cited by
-
Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case-Control Studies.Cancers (Basel). 2022 Sep 29;14(19):4774. doi: 10.3390/cancers14194774. Cancers (Basel). 2022. PMID: 36230696 Free PMC article. Review.
-
An update on the management of breast cancer in Africa.Infect Agent Cancer. 2017 Feb 14;12:13. doi: 10.1186/s13027-017-0124-y. eCollection 2017. Infect Agent Cancer. 2017. PMID: 28228841 Free PMC article. Review.
-
Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.PLoS One. 2016 Dec 19;11(12):e0168730. doi: 10.1371/journal.pone.0168730. eCollection 2016. PLoS One. 2016. PMID: 27992550 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
